The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Angiotensin-Converting Enzyme 2 Suppresses Pathological Hypertrophy, Myocardial Fibrosis, and Cardiac Dysfunction
Abstract
Background—Angiotensin-converting enzyme 2 (ACE2) is a pleiotropic monocarboxypeptidase capable of metabolizing several peptide substrates. We hypothesized that ACE2 is a negative regulator of angiotensin II (Ang II)–mediated signaling and its adverse effects on the cardiovascular system. Methods and Results—Ang II infusion (1.5 mg · kg−1· d−1) for 14 days resulted in worsening cardiac fibrosis and pathological hypertrophy in ACE2 knockout (Ace2−/y) mice compared with wild-type (WT) mice. Daily treatment of Ang II–infused wild-type mice with recombinant human ACE2 (rhACE2; 2 mg · kg−1· d−1 IP) blunted the hypertrophic response and expression of hypertrophy markers and reduced Ang II–induced superoxide production. Ang II–mediated myocardial fibrosis and expression of procollagen type Iα1, procollagen type IIIα1, transforming growth factor-β1, and fibronectin were also suppressed by rhACE2. Ang II–induced diastolic dysfunction was inhibited by rhACE2 in association with reduced plasma and myocardial Ang II and increased plasma Ang 1-7 levels. rhACE2 treatment inhibited Ang II–mediated activation of protein kinase C-α and protein kinase C-β1 protein levels and phosphorylation of the extracellular signal-regulated 1/2, Janus kinase 2, and signal transducer and activator of transcription 3 signaling pathways in wild-type mice. A subpressor dose of Ang II (0.15 mg · kg−1· d−1) resulted in a milder phenotype that was strikingly attenuated by rhACE2 (2 mg · kg−1· d−1 IP). In adult ventricular cardiomyocytes and cardiofibroblasts, Ang II–mediated superoxide generation, collagen production, and extracellular signal-regulated 1/2 signaling were inhibited by rhACE2 in an Ang 1-7–dependent manner. Importantly, rhACE2 partially prevented the development of dilated cardiomyopathy in pressure-overloaded wild-type mice. Conclusions—Elevated Ang II induced hypertension, myocardial hypertrophy, fibrosis, and diastolic dysfunction, which were exacerbated by ACE2 deficiency, whereas rhACE2 attenuated Ang II– and pressure-overload–induced adverse myocardial remodeling. Hence, ACE2 is an important negative regulator of Ang II–induced heart disease and suppresses adverse myocardial remodeling.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The natural history of congestive heart failure: the Framingham study
McKee, P. A., Castelli, W. P., McNamara, P. M., & Kannel, W. B. (1971) · New England Journal of Medicine · doi:10.1056/nejm197112232852601 · Cited by 3,448
Donoghue, M., Hsieh, F., Baronas, E., Godbout, K., Gosselin, M., Stagliano, N., Donovan, M., Woolf, B., Robison, K., Jeyaseelan, R., et al. (2000) · Circulation Research · doi:10.1161/01.res.87.5.e1 · Cited by 2,485
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,027
A Human Homolog of Angiotensin-converting Enzyme
Tipnis, S. R., Hooper, N. M., Hyde, R., Karran, E., Christie, G., & Turner, A. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002615200 · Cited by 2,009
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Mehta, P. K., & Griendling, K. K. (2007) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00287.2006 · Cited by 1,924
Regulation of cardiac hypertrophy by intracellular signalling pathways
Heineke, J., & Molkentin, J. D. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1983 · Cited by 1,866
Angiotensin-converting enzyme 2 is an essential regulator of heart function
Crackower, M. A., Sarao, R., Oudit, G. Y., Yagil, C., Kozieradzki, I., Scanga, S. E., Oliveira-dos-Santos, A. J., da Costa, J., Zhang, L., Pei, Y., et al. (2002) · Nature · doi:10.1038/nature00786 · Cited by 1,733
Self-citationHydrolysis of Biological Peptides by Human Angiotensin-converting Enzyme-related Carboxypeptidase
Vickers, C., Hales, P., Kaushik, V., Dick, L., Gavin, J., Tang, J., Godbout, K., Parsons, T., Baronas, E., Hsieh, F., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200581200 · Cited by 1,407
Molecular and Cellular Mechanisms of Angiotensin II-Mediated Cardiovascular and Renal Diseases
Kim, S., & Iwao, H. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01434-0 · Cited by 983
Oxidative Stress and Cardiovascular Injury: Part I: Basic Mechanisms and In Vivo Monitoring of ROS
Griendling, K. K., & FitzGerald, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000093660.86242.bb · Cited by 941
Zile, M. R., & Brutsaert, D. L. (2002) · Circulation · doi:10.1161/hc1202.105290 · Cited by 887
Role of Oxidative Stress in Cardiac Hypertrophy and Remodeling
Takimoto, E., & Kass, D. A. (2007) · Hypertension · doi:10.1161/01.hyp.0000254415.31362.a7 · Cited by 770
Pacher, P., Nagayama, T., Mukhopadhyay, P., Bátkai, S., & Kass, D. A. (2008) · Nature Protocols · doi:10.1038/nprot.2008.138 · Cited by 734
Oxidative Stress and Cardiovascular Injury: Part II: Animal and Human Studies
Griendling, K. K., & FitzGerald, G. A. (2003) · Circulation · doi:10.1161/01.cir.0000093661.90582.c4 · Cited by 721
Yu, C.-M., Sanderson, J. E., Marwick, T. H., & Oh, J. K. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.01.078 · Cited by 571
Angiotensin II and Renal Fibrosis
Mezzano, S. A., Ruiz-Ortega, M., & Egido, J. (2001) · Hypertension · doi:10.1161/hy09t1.094234 · Cited by 523
Drugs targeting the renin–angiotensin–aldosterone system
Zaman, M. A., Oparil, S., & Calhoun, D. A. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd873 · Cited by 439
Isolation and Culture of Adult Mouse Cardiac Myocytes
O'Connell, T. D., Rodrigo, M. C., & Simpson, P. C. (2006) · Cardiovascular Proteomics · doi:10.1385/1-59745-214-9:271 · Cited by 342
Altered blood pressure responses and normal cardiac phenotype in ACE2-null mice
Gurley, S. B., Allred, A., Le, T. H., Griffiths, R., Mao, L., Philip, N., Haystead, T. A., Donoghue, M., Breitbart, R. E., Acton, S. L., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci16980 · Cited by 334
Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1–7)
Grobe, J. L., Mecca, A. P., Lingis, M., Shenoy, V., Bolton, T. A., Machado, J. M., Speth, R. C., Raizada, M. K., & Katovich, M. J. (2007) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00937.2006 · Cited by 332
Yamamoto, K., Ohishi, M., Katsuya, T., Ito, N., Ikushima, M., Kaibe, M., Tatara, Y., Shiota, A., Sugano, S., Takeda, S., et al. (2006) · Hypertension · doi:10.1161/01.hyp.0000205833.89478.5b · Cited by 323
Angiotensin-(1–7) inhibits growth of cardiac myocytes through activation of the mas receptor
Tallant, E. A., Ferrario, C. M., & Gallagher, P. E. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00941.2004 · Cited by 318
Human Recombinant ACE2 Reduces the Progression of Diabetic Nephropathy
Oudit, G. Y., Liu, G. C., Zhong, J., Basu, R., Chow, F. L., Zhou, J., Loibner, H., Janzek, E., Schuster, M., Penninger, J. M., et al. (2010) · Diabetes · doi:10.2337/db09-1218 · Cited by 300
Self-citationKoka, V., Huang, X. R., Chung, A. C. K., Wang, W., Truong, L. D., & Lan, H. Y. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070762 · Cited by 271
Pfeffer, J. M., Pfeffer, M. A., Mirsky, I., & Braunwald, E. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.10.3310 · Cited by 264
The Role of ACE2 in Cardiovascular Physiology
Oudit, G. Y., Crackower, M. A., Backx, P. H., & Penninger, J. M. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00233-5 · Cited by 254
Self-citationOUDIT, G., KASSIRI, Z., PATEL, M., CHAPPELL, M., BUTANY, J., BACKX, P., TSUSHIMA, R., SCHOLEY, J., KHOKHA, R., & PENNINGER, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.04.007 · Cited by 245
Self-citationIwata, M., Cowling, R. T., Gurantz, D., Moore, C., Zhang, S., Yuan, J. X.-J., & Greenberg, B. H. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00317.2005 · Cited by 231
Vascular gp91 phox : Beyond the Endothelium
Pagano, P. J. (2000) · Circulation Research · doi:10.1161/01.res.87.1.1 · Cited by 229
Angiotensin(1-7) Blunts Hypertensive Cardiac Remodeling by a Direct Effect on the Heart
Mercure, C., Yogi, A., Callera, G. E., Aranha, A. B., Bader, M., Ferreira, A. J., Santos, R. A. S., Walther, T., Touyz, R. M., & Reudelhuber, T. L. (2008) · Circulation Research · doi:10.1161/circresaha.108.184911 · Cited by 226
Kassiri, Z., Zhong, J., Guo, D., Basu, R., Wang, X., Liu, P. P., Scholey, J. W., Penninger, J. M., & Oudit, G. Y. (2009) · Circulation: Heart Failure · doi:10.1161/circheartfailure.108.840124 · Cited by 226
Self-citationEpelman, S., Shrestha, K., Troughton, R. W., Francis, G. S., Sen, S., Klein, A. L., & Wilson Tang, W. H. (2009) · Journal of Cardiac Failure · doi:10.1016/j.cardfail.2009.01.014 · Cited by 200
ACE2 gene transfer attenuates hypertension-linked pathophysiological changes in the SHR
Díez-Freire, C., Vázquez, J., Correa de Adjounian, M. F., Ferrari, M. F. R., Yuan, L., Silver, X., Torres, R., & Raizada, M. K. (2006) · Physiological Genomics · doi:10.1152/physiolgenomics.00312.2005 · Cited by 200
Booz, G. W., Day, J. N. E., & Baker, K. M. (2002) · Journal of Molecular and Cellular Cardiology · doi:10.1006/jmcc.2002.2076 · Cited by 172
Kassiri, Z., Oudit, G. Y., Sanchez, O., Dawood, F., Mohammed, F. F., Nuttall, R. K., Edwards, D. R., Liu, P. P., Backx, P. H., & Khokha, R. (2005) · Circulation Research · doi:10.1161/01.res.0000178789.16929.cf · Cited by 165
Self-citationBasu, R., Oudit, G. Y., Wang, X., Zhang, L., Ussher, J. R., Lopaschuk, G. D., & Kassiri, Z. (2009) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00452.2009 · Cited by 161
Self-citationTsai, C., Lai, L., Kuo, K., Hwang, J., Hsieh, C.-S., Hsu, K.-L., Tseng, C.-D., Tseng, Y.-Z., Chiang, F., & Lin, J.-L. (2008) · Circulation · doi:10.1161/circulationaha.107.695346 · Cited by 148
Zhou, Y., Foster, F. S., Nieman, B. J., Davidson, L., Chen, X., & Henkelman, R. M. (2004) · Physiological Genomics · doi:10.1152/physiolgenomics.00026.2004 · Cited by 146
Zhong, J., Huang, D., Yang, Y., Li, Y., Liu, G., Song, X., & Du, K. (2004) · Hypertension · doi:10.1161/01.hyp.0000146400.57221.74 · Cited by 131
Self-citationCurrent Perspectives on Cardiac Function in Patients With Diastolic Heart Failure
Wang, J., & Nagueh, S. F. (2009) · Circulation · doi:10.1161/circulationaha.108.822676 · Cited by 91
Klein, G. G., Schaefer, A., Hilfiker‐Kleiner, D., Oppermann, D., Shukla, P. C., Guba‐Quint, A., Podewski, E., Hilfiker, A., Schröder, F., Leitges, M., et al. (2005) · Circulation Research · doi:10.1161/01.res.0000161999.86198.1e · Cited by 88
Biochemical markers of myocardial remodelling in hypertensive heart disease
González, A., López, B., Ravassa, S., Beaumont, J., Arias, T., Hermida, N., Zudaire, A., & Dı́ez, J. (2008) · Cardiovascular Research · doi:10.1093/cvr/cvn235 · Cited by 87
Billet, S., Bardin, S., Verp, S., Baudrie, V., Michaud, A., Conchon, S., Muffat‐Joly, M., Escoubet, B., Souil, E., Hamard, G., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci28764 · Cited by 83
Evaluation of left ventricular diastolic function by pulsed Doppler tissue imaging in mice
Schaefer, A., Klein, G., Brand, B., Lippolt, P., Drexler, H., & Meyer, G. P. (2003) · Journal of the American Society of Echocardiography · doi:10.1067/s0894-7317(03)00679-5 · Cited by 74
Convergence of Protein Kinase C and JAK-STAT Signaling on Transcription Factor GATA-4
Wang, J., Paradis, P., Aries, A., Komati, H., Lefèbvre, C., Wang, H., & Nemer, M. J. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.22.9829-9844.2005 · Cited by 68
Garabelli, P. J., Modrall, J. G., Penninger, J. M., Ferrario, C. M., & Chappell, M. C. (2008) · Experimental Physiology · doi:10.1113/expphysiol.2007.040246 · Cited by 66
Self-citationAbnormal cardiac inflow patterns during postnatal development in a mouse model of Holt-Oram syndrome
Zhou, Y., Zhu, Y., Bishop, J. E., Davidson, L., Henkelman, R. M., Bruneau, B. G., & Foster, F. S. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00027.2005 · Cited by 55
Zhong, J., Yu, X., Lin, Q., Li, X., Huang, X., Xiao, D., & Lin, S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707482 · Cited by 48
Self-citation
Cited by
Gheblawi, M., Wang, K., Viveiros, A., Nguyen, Q., Zhong, J.-C., Turner, A. J., Raizada, M. K., Grant, M. B., & Oudit, G. Y. (2020) · Circulation Research · doi:10.1161/circresaha.120.317015 · Cited by 1,882
Self-citationThe pivotal link between ACE2 deficiency and SARS-CoV-2 infection
Verdecchia, P., Cavallini, C., Spanevello, A., & Angeli, F. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.04.037 · Cited by 1,237
“bation of hypertension and cardiac hypertrophy induced by angiotensin II, [66] and maladaptive left ventricular remodeling after myocardial infarction.”
InfluentialRole of angiotensin-converting enzyme 2 (ACE2) in COVID-19
Ni, W., Yang, X., Yang, D., Bao, J., Li, R., Xiao, Y., Hou, C., Wang, H., Liu, J., Yang, D., et al. (2020) · Critical Care · doi:10.1186/s13054-020-03120-0 · Cited by 1,175
Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology
Forrester, S. J., Booz, G. W., Sigmund, C. D., Coffman, T. M., Kawai, T., Rizzo, V., Scalia, R., & Eguchi, S. (2018) · Physiological Reviews · doi:10.1152/physrev.00038.2017 · Cited by 1,095
Role of the ACE2/angiotensin 1-7 axis of the renin-angiotensin system in heart failure
Patel, V. B., Zhong, J.-C., Grant, M. B., & Oudit, G. Y. (2016) · Circulation Research · doi:10.1161/circresaha.116.307708 · Cited by 833
Self-citation
Metadata
- Authors
- Zhong, J., Basu, R., Guo, D., Chow, F. L., Byrns, S., Schuster, M., Loibner, H., Wang, X.-H., Penninger, J. M., Kassiri, Z., & Oudit, G. Y.
- Venue
- Circulation
- Published
- 2010-08-17
- Volume
- 122
- Issue
- 7
- Pages
- 717-728
- ISSN
- 0009-7322 (ISSN-L)
- 1524-4539
- OpenAlex
- W2029269323
- Cited by
- 457
- References
- 48
- FWCI
- 16.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.